The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Coagulation Factor Ⅷ Market Research Report 2025
Synopsis
Human Coagulation Factor Ⅷ is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene result in hemophilia A, an X-linked coagulation disorder Human Coagulation Factor Ⅷ is produced in liver sinusoidal cells and endothelial cells outside the liver throughout the body. This protein circulates in the bloodstream in an inactive form, bound to another molecule called von Willebrand factor, until an injury that damages blood vessels occurs. In response to injury, coagulation factor VIII is activated and separates from von Willebrand factor. The active protein (sometimes written as coagulation factor VIIIa) interacts with another coagulation factor called factor IX. This interaction sets off a chain of additional chemical reactions that form a blood clot.
The global Human Coagulation Factor Ⅷ market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor Ⅷ, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor Ⅷ.
Report Scope
The Human Coagulation Factor Ⅷ market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Coagulation Factor Ⅷ market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor Ⅷ companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
CSL Behring
Baxter
Grifols
Octapharma
Pfizer
Taibang Bio
Shanghai Laishi
Hualan Bio
Guangdong Shuanglin
GreenCross
Pfizer
Segment by Type
Recombinant Factor VIII
Human Factor VIII
Segment by Application
Hemophilia A
Relvent Bleeding Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Coagulation Factor Ⅷ companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Human Coagulation Factor Ⅷ is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene result in hemophilia A, an X-linked coagulation disorder Human Coagulation Factor Ⅷ is produced in liver sinusoidal cells and endothelial cells outside the liver throughout the body. This protein circulates in the bloodstream in an inactive form, bound to another molecule called von Willebrand factor, until an injury that damages blood vessels occurs. In response to injury, coagulation factor VIII is activated and separates from von Willebrand factor. The active protein (sometimes written as coagulation factor VIIIa) interacts with another coagulation factor called factor IX. This interaction sets off a chain of additional chemical reactions that form a blood clot.
The global Human Coagulation Factor Ⅷ market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor Ⅷ, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor Ⅷ.
Report Scope
The Human Coagulation Factor Ⅷ market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Coagulation Factor Ⅷ market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coagulation Factor Ⅷ companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
CSL Behring
Baxter
Grifols
Octapharma
Pfizer
Taibang Bio
Shanghai Laishi
Hualan Bio
Guangdong Shuanglin
GreenCross
Pfizer
Segment by Type
Recombinant Factor VIII
Human Factor VIII
Segment by Application
Hemophilia A
Relvent Bleeding Diseases
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Coagulation Factor Ⅷ companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Recombinant Factor VIII
1.2.3 Human Factor VIII
1.3 Market by Application
1.3.1 Global Human Coagulation Factor Ⅷ Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hemophilia A
1.3.3 Relvent Bleeding Diseases
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Coagulation Factor Ⅷ Market Perspective (2019-2030)
2.2 Human Coagulation Factor Ⅷ Growth Trends by Region
2.2.1 Global Human Coagulation Factor Ⅷ Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Coagulation Factor Ⅷ Historic Market Size by Region (2019-2024)
2.2.3 Human Coagulation Factor Ⅷ Forecasted Market Size by Region (2025-2030)
2.3 Human Coagulation Factor Ⅷ Market Dynamics
2.3.1 Human Coagulation Factor Ⅷ Industry Trends
2.3.2 Human Coagulation Factor Ⅷ Market Drivers
2.3.3 Human Coagulation Factor Ⅷ Market Challenges
2.3.4 Human Coagulation Factor Ⅷ Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Coagulation Factor Ⅷ Players by Revenue
3.1.1 Global Top Human Coagulation Factor Ⅷ Players by Revenue (2019-2024)
3.1.2 Global Human Coagulation Factor Ⅷ Revenue Market Share by Players (2019-2024)
3.2 Global Human Coagulation Factor Ⅷ Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Coagulation Factor Ⅷ Revenue
3.4 Global Human Coagulation Factor Ⅷ Market Concentration Ratio
3.4.1 Global Human Coagulation Factor Ⅷ Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Coagulation Factor Ⅷ Revenue in 2023
3.5 Human Coagulation Factor Ⅷ Key Players Head office and Area Served
3.6 Key Players Human Coagulation Factor Ⅷ Product Solution and Service
3.7 Date of Enter into Human Coagulation Factor Ⅷ Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Coagulation Factor Ⅷ Breakdown Data by Type
4.1 Global Human Coagulation Factor Ⅷ Historic Market Size by Type (2019-2024)
4.2 Global Human Coagulation Factor Ⅷ Forecasted Market Size by Type (2025-2030)
5 Human Coagulation Factor Ⅷ Breakdown Data by Application
5.1 Global Human Coagulation Factor Ⅷ Historic Market Size by Application (2019-2024)
5.2 Global Human Coagulation Factor Ⅷ Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Coagulation Factor Ⅷ Market Size (2019-2030)
6.2 North America Human Coagulation Factor Ⅷ Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Coagulation Factor Ⅷ Market Size by Country (2019-2024)
6.4 North America Human Coagulation Factor Ⅷ Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Coagulation Factor Ⅷ Market Size (2019-2030)
7.2 Europe Human Coagulation Factor Ⅷ Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Coagulation Factor Ⅷ Market Size by Country (2019-2024)
7.4 Europe Human Coagulation Factor Ⅷ Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Coagulation Factor Ⅷ Market Size (2019-2030)
8.2 Asia-Pacific Human Coagulation Factor Ⅷ Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Coagulation Factor Ⅷ Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Coagulation Factor Ⅷ Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Coagulation Factor Ⅷ Market Size (2019-2030)
9.2 Latin America Human Coagulation Factor Ⅷ Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Coagulation Factor Ⅷ Market Size by Country (2019-2024)
9.4 Latin America Human Coagulation Factor Ⅷ Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Coagulation Factor Ⅷ Market Size (2019-2030)
10.2 Middle East & Africa Human Coagulation Factor Ⅷ Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Coagulation Factor Ⅷ Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Coagulation Factor Ⅷ Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Human Coagulation Factor Ⅷ Introduction
11.1.4 Bayer Revenue in Human Coagulation Factor Ⅷ Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 CSL Behring
11.2.1 CSL Behring Company Detail
11.2.2 CSL Behring Business Overview
11.2.3 CSL Behring Human Coagulation Factor Ⅷ Introduction
11.2.4 CSL Behring Revenue in Human Coagulation Factor Ⅷ Business (2019-2024)
11.2.5 CSL Behring Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter Human Coagulation Factor Ⅷ Introduction
11.3.4 Baxter Revenue in Human Coagulation Factor Ⅷ Business (2019-2024)
11.3.5 Baxter Recent Development
11.4 Grifols
11.4.1 Grifols Company Detail
11.4.2 Grifols Business Overview
11.4.3 Grifols Human Coagulation Factor Ⅷ Introduction
11.4.4 Grifols Revenue in Human Coagulation Factor Ⅷ Business (2019-2024)
11.4.5 Grifols Recent Development
11.5 Octapharma
11.5.1 Octapharma Company Detail
11.5.2 Octapharma Business Overview
11.5.3 Octapharma Human Coagulation Factor Ⅷ Introduction
11.5.4 Octapharma Revenue in Human Coagulation Factor Ⅷ Business (2019-2024)
11.5.5 Octapharma Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Human Coagulation Factor Ⅷ Introduction
11.6.4 Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Taibang Bio
11.7.1 Taibang Bio Company Detail
11.7.2 Taibang Bio Business Overview
11.7.3 Taibang Bio Human Coagulation Factor Ⅷ Introduction
11.7.4 Taibang Bio Revenue in Human Coagulation Factor Ⅷ Business (2019-2024)
11.7.5 Taibang Bio Recent Development
11.8 Shanghai Laishi
11.8.1 Shanghai Laishi Company Detail
11.8.2 Shanghai Laishi Business Overview
11.8.3 Shanghai Laishi Human Coagulation Factor Ⅷ Introduction
11.8.4 Shanghai Laishi Revenue in Human Coagulation Factor Ⅷ Business (2019-2024)
11.8.5 Shanghai Laishi Recent Development
11.9 Hualan Bio
11.9.1 Hualan Bio Company Detail
11.9.2 Hualan Bio Business Overview
11.9.3 Hualan Bio Human Coagulation Factor Ⅷ Introduction
11.9.4 Hualan Bio Revenue in Human Coagulation Factor Ⅷ Business (2019-2024)
11.9.5 Hualan Bio Recent Development
11.10 Guangdong Shuanglin
11.10.1 Guangdong Shuanglin Company Detail
11.10.2 Guangdong Shuanglin Business Overview
11.10.3 Guangdong Shuanglin Human Coagulation Factor Ⅷ Introduction
11.10.4 Guangdong Shuanglin Revenue in Human Coagulation Factor Ⅷ Business (2019-2024)
11.10.5 Guangdong Shuanglin Recent Development
11.11 GreenCross
11.11.1 GreenCross Company Detail
11.11.2 GreenCross Business Overview
11.11.3 GreenCross Human Coagulation Factor Ⅷ Introduction
11.11.4 GreenCross Revenue in Human Coagulation Factor Ⅷ Business (2019-2024)
11.11.5 GreenCross Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Human Coagulation Factor Ⅷ Introduction
11.12.4 Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2019-2024)
11.12.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Human Coagulation Factor Ⅷ Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Recombinant Factor VIII
Table 3. Key Players of Human Factor VIII
Table 4. Global Human Coagulation Factor Ⅷ Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Human Coagulation Factor Ⅷ Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Human Coagulation Factor Ⅷ Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Human Coagulation Factor Ⅷ Market Share by Region (2019-2024)
Table 8. Global Human Coagulation Factor Ⅷ Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Human Coagulation Factor Ⅷ Market Share by Region (2025-2030)
Table 10. Human Coagulation Factor Ⅷ Market Trends
Table 11. Human Coagulation Factor Ⅷ Market Drivers
Table 12. Human Coagulation Factor Ⅷ Market Challenges
Table 13. Human Coagulation Factor Ⅷ Market Restraints
Table 14. Global Human Coagulation Factor Ⅷ Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Human Coagulation Factor Ⅷ Market Share by Players (2019-2024)
Table 16. Global Top Human Coagulation Factor Ⅷ Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor Ⅷ as of 2023)
Table 17. Ranking of Global Top Human Coagulation Factor Ⅷ Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Human Coagulation Factor Ⅷ Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Coagulation Factor Ⅷ Product Solution and Service
Table 21. Date of Enter into Human Coagulation Factor Ⅷ Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Coagulation Factor Ⅷ Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Human Coagulation Factor Ⅷ Revenue Market Share by Type (2019-2024)
Table 25. Global Human Coagulation Factor Ⅷ Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Human Coagulation Factor Ⅷ Revenue Market Share by Type (2025-2030)
Table 27. Global Human Coagulation Factor Ⅷ Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Human Coagulation Factor Ⅷ Revenue Market Share by Application (2019-2024)
Table 29. Global Human Coagulation Factor Ⅷ Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Human Coagulation Factor Ⅷ Revenue Market Share by Application (2025-2030)
Table 31. North America Human Coagulation Factor Ⅷ Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Human Coagulation Factor Ⅷ Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Human Coagulation Factor Ⅷ Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Human Coagulation Factor Ⅷ Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Human Coagulation Factor Ⅷ Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Human Coagulation Factor Ⅷ Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Human Coagulation Factor Ⅷ Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Human Coagulation Factor Ⅷ Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Human Coagulation Factor Ⅷ Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Coagulation Factor Ⅷ Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Human Coagulation Factor Ⅷ Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Human Coagulation Factor Ⅷ Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Human Coagulation Factor Ⅷ Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Human Coagulation Factor Ⅷ Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Human Coagulation Factor Ⅷ Market Size by Country (2025-2030) & (US$ Million)
Table 46. Bayer Company Detail
Table 47. Bayer Business Overview
Table 48. Bayer Human Coagulation Factor Ⅷ Product
Table 49. Bayer Revenue in Human Coagulation Factor Ⅷ Business (2019-2024) & (US$ Million)
Table 50. Bayer Recent Development
Table 51. CSL Behring Company Detail
Table 52. CSL Behring Business Overview
Table 53. CSL Behring Human Coagulation Factor Ⅷ Product
Table 54. CSL Behring Revenue in Human Coagulation Factor Ⅷ Business (2019-2024) & (US$ Million)
Table 55. CSL Behring Recent Development
Table 56. Baxter Company Detail
Table 57. Baxter Business Overview
Table 58. Baxter Human Coagulation Factor Ⅷ Product
Table 59. Baxter Revenue in Human Coagulation Factor Ⅷ Business (2019-2024) & (US$ Million)
Table 60. Baxter Recent Development
Table 61. Grifols Company Detail
Table 62. Grifols Business Overview
Table 63. Grifols Human Coagulation Factor Ⅷ Product
Table 64. Grifols Revenue in Human Coagulation Factor Ⅷ Business (2019-2024) & (US$ Million)
Table 65. Grifols Recent Development
Table 66. Octapharma Company Detail
Table 67. Octapharma Business Overview
Table 68. Octapharma Human Coagulation Factor Ⅷ Product
Table 69. Octapharma Revenue in Human Coagulation Factor Ⅷ Business (2019-2024) & (US$ Million)
Table 70. Octapharma Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer Human Coagulation Factor Ⅷ Product
Table 74. Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2019-2024) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Taibang Bio Company Detail
Table 77. Taibang Bio Business Overview
Table 78. Taibang Bio Human Coagulation Factor Ⅷ Product
Table 79. Taibang Bio Revenue in Human Coagulation Factor Ⅷ Business (2019-2024) & (US$ Million)
Table 80. Taibang Bio Recent Development
Table 81. Shanghai Laishi Company Detail
Table 82. Shanghai Laishi Business Overview
Table 83. Shanghai Laishi Human Coagulation Factor Ⅷ Product
Table 84. Shanghai Laishi Revenue in Human Coagulation Factor Ⅷ Business (2019-2024) & (US$ Million)
Table 85. Shanghai Laishi Recent Development
Table 86. Hualan Bio Company Detail
Table 87. Hualan Bio Business Overview
Table 88. Hualan Bio Human Coagulation Factor Ⅷ Product
Table 89. Hualan Bio Revenue in Human Coagulation Factor Ⅷ Business (2019-2024) & (US$ Million)
Table 90. Hualan Bio Recent Development
Table 91. Guangdong Shuanglin Company Detail
Table 92. Guangdong Shuanglin Business Overview
Table 93. Guangdong Shuanglin Human Coagulation Factor Ⅷ Product
Table 94. Guangdong Shuanglin Revenue in Human Coagulation Factor Ⅷ Business (2019-2024) & (US$ Million)
Table 95. Guangdong Shuanglin Recent Development
Table 96. GreenCross Company Detail
Table 97. GreenCross Business Overview
Table 98. GreenCross Human Coagulation Factor Ⅷ Product
Table 99. GreenCross Revenue in Human Coagulation Factor Ⅷ Business (2019-2024) & (US$ Million)
Table 100. GreenCross Recent Development
Table 101. Pfizer Company Detail
Table 102. Pfizer Business Overview
Table 103. Pfizer Human Coagulation Factor Ⅷ Product
Table 104. Pfizer Revenue in Human Coagulation Factor Ⅷ Business (2019-2024) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Coagulation Factor Ⅷ Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Human Coagulation Factor Ⅷ Market Share by Type: 2023 VS 2030
Figure 3. Recombinant Factor VIII Features
Figure 4. Human Factor VIII Features
Figure 5. Global Human Coagulation Factor Ⅷ Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Human Coagulation Factor Ⅷ Market Share by Application: 2023 VS 2030
Figure 7. Hemophilia A Case Studies
Figure 8. Relvent Bleeding Diseases Case Studies
Figure 9. Human Coagulation Factor Ⅷ Report Years Considered
Figure 10. Global Human Coagulation Factor Ⅷ Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Human Coagulation Factor Ⅷ Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Human Coagulation Factor Ⅷ Market Share by Region: 2023 VS 2030
Figure 13. Global Human Coagulation Factor Ⅷ Market Share by Players in 2023
Figure 14. Global Top Human Coagulation Factor Ⅷ Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor Ⅷ as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Human Coagulation Factor Ⅷ Revenue in 2023
Figure 16. North America Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Human Coagulation Factor Ⅷ Market Share by Country (2019-2030)
Figure 18. United States Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Human Coagulation Factor Ⅷ Market Share by Country (2019-2030)
Figure 22. Germany Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Human Coagulation Factor Ⅷ Market Share by Region (2019-2030)
Figure 30. China Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Human Coagulation Factor Ⅷ Market Share by Country (2019-2030)
Figure 38. Mexico Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Human Coagulation Factor Ⅷ Market Share by Country (2019-2030)
Figure 42. Turkey Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Human Coagulation Factor Ⅷ Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Bayer Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2019-2024)
Figure 45. CSL Behring Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2019-2024)
Figure 46. Baxter Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2019-2024)
Figure 47. Grifols Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2019-2024)
Figure 48. Octapharma Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2019-2024)
Figure 50. Taibang Bio Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2019-2024)
Figure 51. Shanghai Laishi Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2019-2024)
Figure 52. Hualan Bio Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2019-2024)
Figure 53. Guangdong Shuanglin Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2019-2024)
Figure 54. GreenCross Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2019-2024)
Figure 55. Pfizer Revenue Growth Rate in Human Coagulation Factor Ⅷ Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
